BMP meets AML: induction of BMP signaling by a novel fusion gene promotes pediatric acute leukemia
- PMID: 23153530
- PMCID: PMC3501979
- DOI: 10.1016/j.ccr.2012.10.008
BMP meets AML: induction of BMP signaling by a novel fusion gene promotes pediatric acute leukemia
Abstract
In this issue of Cancer Cell, Gruber et al. report that a significant proportion of children with acute megakaryoblastic leukemia acquire a translocation that confers enhanced BMP signaling and promotes self-renewal of hematopoietic progenitors. This study presents novel therapeutic targets that may lead to improved therapies for this aggressive leukemia.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
Comment on
-
An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.Cancer Cell. 2012 Nov 13;22(5):683-97. doi: 10.1016/j.ccr.2012.10.007. Cancer Cell. 2012. PMID: 23153540 Free PMC article.
References
-
- Ge Y, Jensen TL, Stout ML, Flatley RM, Grohar PJ, Ravindranath Y, Matherly LH, Taub JW. The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines. Cancer Res. 2004;64:728–735. - PubMed
-
- Greaves MF, Wiemel J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3:639–649. - PubMed
-
- Gruber, et al. (this issue)
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
